LTB4-Driven Inflammation and Increased Expression of ALOX5/ACE2 During Severe COVID-19 in Individuals With Diabetes

doi:10.2337/db20-1260

PMC full text:

Diabetes. 2021 Sep; 70(9): 2120–2130.

Published online 2021 Jun 15. doi: 10.2337/db20-1260

Copyright/LicenseRequest permission to reuse: Copyright © 2021 by the American Diabetes Association
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.

<< PrevFigure 2Next >>

Figure 2

An external file that holds a picture, illustration, etc.
Object name is db201260f2.jpg

Increased expression of ALOX5 and ACE2/TMPRSS2 receptor system for SARS-CoV-2 infection in individuals with COVID-19 in the DM group. Expressions of ALOX5 (A), ACE2 (B), TMPRSS2 (C), FURIN (D), and CD147 (E) in PBMCs from DM and NDM patients. Data are means. *P < 0.05, **P < 0.01.

Figure 2

Images in this article

Click on the image to see a larger version.